# Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma

> **NCT01159574** · PHASE2 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 121 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** dexamethasone
- **DRUG:** clarithromycin
- **DRUG:** Pomalidomide

## Key facts

- **NCT ID:** NCT01159574
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2015-05-05
- **Final completion:** 2015-05-05
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2019-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01159574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01159574, "Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01159574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*